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Influenza nucleoprotein (NP)-specific T-cell receptor transgenic mice (F5) were crossed
with transgenic mice expressing the cognate antigenic protein under the control of the H-
2K promoter. Double-transgenic mice show negative selection of thymocytes at the
CD4+8+TCR1 to CD4+8/TCRhi transition stage. A few CD8 T cells, however, escape clonal
deletion, and in the peripheral lymphoid organs of these mice, they exhibit low levels of
the transgenic receptor and upregulated levels of the CD44 memory marker. Such cells do
not proliferate upon exposure to antigen stimulation in vivo or ex vivo, however, they can
develop low but detectable levels of antigen-specific cytotoxic function after stimulation
in vitro in the presence of IL-2.
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INTRODUCTION
Achieving and maintaining self-tolerance are of cen-
tral importance for an effective immune system. In
the case of T-cell tolerance, this is generally accom-
plished by elimination of self-reactive cells either
during development in the thymus (Kappler et al.,
1987; MacDonald et al., 1988) or after encountering
self-antigen in the periphery (Jones et al., 1990; Webb
et al., 1990; Kawabe and Ochi, 1991; Rocha et al.,
1992); however, some potentially autoreactive cells
are not physically deleted but are rendered unre-
sponsive to self-antigens (Schwartz, 1989; Blackman
et al., 1990; Ramsdell and Fowlkes, 1990). Such cells
can be permanently incapacitated in their ability to
respond to antigen or can be restimulated in vitro or
in vivo by exposure to high levels of antigen and/or
to different cytokines. The unresponsiveness main-
tained in some nondeletional tolerant states has been
attributed to the downregulation of the reactiveTCR
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(Sch6nrich et al., 1991) and/or the coreceptor CD4
or CD8 (Rocha et al., 1992). In addition, other fac-
tors such as transcription levels of certain genes or
efficiency in costimulation and signal transduction
may be affected in this process (Mueller et al., 1989).
It is important to understand the mechanisms
underlying the induction and maintenance of the
tolerant state of T cells in order to be able to inter-
vene in cases where their untimely activation causes
autoimmune disease. To study the phenomenon in
more controlled situations, several groups have fol-
lowed a strategy that attempts to keep one or more
of the participating elements constant. Such central
candidates are the T-cell receptor (TCR) and the
cognate antigen: Thus, T-cell-receptor (TCR) trans-
genic mice have been crossed to mice that express
the cognate antigen.
We have generated a TCR transgenic mouse that
bears on most of its T cells a TCR (F5) that recog-
nizes a nonamer peptide (366-374; NP peptide)
from the influenza virus (A/NT/60/68) nucleo-
protein in the context of class IMHC (Db) (Townsend
et al., 1986; Mamalaki et al., 1993a). Most T cells in
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F5 TCR transgenic mice are CD8 cytotoxic cells and
can respond to the cognate antigen (peptide or viral
protein) both in vivo and in vitro (Mamalaki et al.,
1992, 1993a). The utilization by the receptor of the
V131 member of the -chain gene family also confers
reactivity to endogenous superantigens (Mtv 8, 9,
and 11) when presented by H-2E class IIMHC mol-
ecules (Dyson et al., 1991). In the past, we have re-
ported the creation of a tolerant state in F5 TCR
transgenic mice when they are crossed with H-2E
mice carrying Mtv8 and Mtv9 (Mamalaki et al.,
1993a). In that case, we demonstrated that hybrids
of F5 mice bred with CBA (H-2k) or BALB/c (H-2d)
mice lack double-positive thymocytes that express
high levels of TCR and as a consequence a reduc-
tion in single-positive mature T-cells. CD4 cells in
the periphery of these mice are more severely af-
fected in that there are fewer CD4 cells expressing
Vl compared to F5 H-2bb mice. A substantial num-
ber of CD8 cells, however, with low levels of V[3
transgenic chains accumulate in the peripheral
lymphoid organs of F5/H2E mice. The circulating
CD8 cells from E+/Mtv8+9 mice (even from those
backcross animals homozygous for the H-2k haplo-
type) can be stimulated in vitro to differentiate into
cytotoxic effector cells that can kill target cells in an
NP-antigen-specific manner (Mamalaki et al., 1993a).
This showed that T cells can be tolerant to one kind
of antigen (endogenous superantigen in this case),
but retain their ability to respond to nominal anti-
gen (NP peptide).
To assess the development of F5 T cells and study
the mechanisms of tolerance induction in transgenic
mice in which the cognate antigen influenza nucleo-
protein is a self-antigen, we generated transgenic
mice that express the viral protein under the broadly
active H-2Kb promoter. Double-transgenic mice
(F5TCR/H2NP) were assessed for F5 T-cell devel-
opment and for their ability to respond to nucleo-
protein antigen. Such mice appear tolerant mainly
due to deletion of CD4+8/TCRhi thymocytes with
the concomitant reduction in output of single-
positive mature T cells. However, a small number of
CD8+VI cells appear in the periphery. These cells
express lower levels of F5 TCR in comparison with
T cells from F5 mice that do not express influenza
nucleoprotein, they express high levels of CD44, and
they are unable to respond to peptide antigenic
stimulation in vivo. In vitro, they fail to proliferate in
response to peptide, but can develop effector func-
tion after culture with the cytokine IL-2 for several
days.
This system represents an experimental model of
nondeletional tolerance that will allow the dissec-
H-2Kb promoter
IMP1295 influenza nucleoprotein sequences
SV40 Tag splice ard polyadenyltion sequerues
SV 40 Tag splice and polyadenylation sequences
FIGURE 1. Influenza nucleoprotein expression construct used to generate H2NP transgenic mice.TOLERANCE IN NUCLEOPROTEIN/F5TCR DOUBLE-TRANSGENIC MICE 301
tion of biochemical mechanisms of maintenance of
tolerance as well as its protential reversal, which
could lead to autoimmunity.
RESULTS
Generation of Influenza Nucleoprotein
Transgenic Mice
In order to generate mice expressing a transgenic
influenza nucleoprotein, we placed the expression
of the transgene under the control of the widely
expressed Class I MHC promoter H-2Kb (H2NP)
(Weiss et al., 1983). The gene for nucleoprotein in
these constructs is a deletion mutant (IMP1295) of
the full gene (Davey et al., 1985; Townsend et al.,
1985). The deletion removes 0c3 to 327 from the N’
terminal portion of the protein and probably renders
the protein nonfunctional and, thus, less likely to be
harmful when expressed in the transgenic mouse
cells. However, it contains the part of the protein that
gives rise to the epitope (0c366-374) recognized by
the F5 TCR (Townsend et al., 1986). The H-2Kb pro-
moter was joined to the deleted NP gene, and an
intron and poly-A signal from the SV40 T antigen
were added to generate the H2NP construct (Fig. 1).
In transgenic mice expressing this construct, the
foreign antigen becomes a self-protein expressed in
most cells of the body.
The construct was injected into fertilized mouse
(C57B1/10) eggs and several transgenic lines were
generated: four of these were used in this study
(H2NP10, H2NP22, H2NP40, and H2NP47). The
messenger RNA for the nucleoprotein proved to be
too unstable to allow us to perform Northern analy-
sis studies for expression. Polymerase chain reaction
(PCR) on RNA from tissues of NP transgenic-mice
assays, however, established that the transgene was
expressed in these mice (data not shown).
Antigen-Presenting Cells in H2NP Transgenic
Mice Express and Present Influenza
Nucleoprotein Peptides
In order to assess the level of expression of nucleo-
protein by professional antigen-presenting cells
(APC) in lymphoid organs of H2NP mice, macro-
phages and dendritic cells from the spleen or the
thymus of these mice were isolated and used to
stimulate F5 T cells. Figure 2 shows the prolifera-
tion of F5 T cells after incubation with H2bb (C57B1 /
10) APC, H2bbAPC loaded withNP peptide, or with
APC from H2NP40 and H2NP47 mice. The results
show that peripheral (Fig. 2A) and thymic (Fig. 2B)
antigen-presenting cells from H2NP40 mice can
stimulate F5 T cells with similar efficiency as H2bb
APC loaded with NP peptide. Similar results were
obtained using APCs from H2NP22 mice (data not
shown). This confirms expression of the NP trans-
gene inAPCs of these mice. Antigen-presenting cells
from the spleen or thymus of H2NP47 mice, on the
other hand, stimulated F5 T cells to a lesser extent
but consistently above background. This indicates
that expression of NP in H2NP47 transgenic mice is
lower than that found in H2NP22 or H2NP40 mice.
Generation of Double (F5/NP)-Transgenic Mice
To assess the effects of an antigenic molecule ex-
pressed as self-protein on the development of F5 T
cells, the H2NP transgenic mice were crossed with
the F5 TCR transgenic mice. F5/H2NP double-
transgenic mice were analyzed byFACS analysis and
their T-cell development was compared with that
seen in F5(H-2b) single-transgenic mice. The abso-
lute numbers of thymocytes showed a tendency to
be reduced in mice expressing transgenic nucleo-
protein. For example, F5/H2NP10 double-transgenic
mice showed approximately one-third to one-half
the number of thymocytes seen in F5 control mice.
Figure3Ashows thymocytes from double-transgenic
mice stained for CD4 and CD8. In all double-
transgenic mice, we observed that the proportion of
CD4/8 and the absolute numbers ofCD4 cells were
not affected, whereas the proportion of thy-
mocytes that developed into fully mature CD8/4
cells was reduced. The percentage numbers of
Fig. 3A in the lower right quadrant includes cells
with downregulated coreceptor levels (probably due
to negative selection) and these numbers do not
reflect genuine CD8 single-positive cells.
Three-color FACS analysis of F5 thymocytes
stained with antibodies against CD4, CD8, andVu
normally shows two populations of cells with dif-
ferent levels of TCR (Fig. 3C): one that stains dull
for TCR (TCR1) and represents the majority of dou-
ble-positive immature thymocytes (Mamalaki et al.,
1993a); and a brightly staining population (TCRhi)
that represents mainly single-positive mature T cells
and those double-positive cells that have already
upregulated their TCR, including the intermediate
populations CD4+8I and CD48 (Mamalaki et al.,302 C. MAMALAKI et al.
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FIGURE 2. In vitro proliferation of F5/RAG-/- T cells in the presence of NP macrophages and dendritic cells. T cells from F5/
RAG-/- spleens were stimulated in vitro by dendritic cells (DC) and macrophages (M) isolated from (A) spleens and (B) thymuses
ofNP40 and NP47 mice. B10 DC andM from the same tissues, loaded with the antigenic peptide beforehand and then washed, were
used as a positive control. Proliferation of the responders was measured by 3H-thymidine incorporation.TOLERANCE IN NUCLEOPROTEIN/F5TCR DOUBLE-TRANSGENIC MICE 303
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FIGURE 3. Absence of TCRTM cells in the thymus of F5/H-2NP double-transgenic mice. Three color fluorometric analysis was
performed on thymocytes of TCR single-transgenic mice or TCR/NP double-transgenic mice before (A) or after (B) intraperitoneal
treatment for 4 days with 50 n moles of antigenic peptide. Cells were stained with anti-CD8 FITC, anti-CD4 PE, and biotinylated
anti-Vu followed by Tricolor-conjugated streptavidin as described in Materials and Methods. Dot blots represent two-color ana-
lysis of cells stained with CD4 and CD8. Numbers represent percent proportion of cells in the quadrant. (C) Three-parameter data
files were software-gated to generate single-color staining histograms ofVI expression on total thymocytes. Numbers indicate the
mean fluorescence ofVI staining in arbitrary units. Solid line: VI expression on total thymocytes from double-transgenic mice.
Dashed line:V expression on total thymocytes from the control F5 single-transgenic mouse.304 C. MAMALAKI et al.
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FIGURE 4. Double-transgenic mice have reduced numbers ofCD8 peripheral T cells with low levels of transgenic receptor. Three-
color fluorometric analysis was performed on lymph node cells ofTCR single-transgenic mice or TCR/NP double-transgenic mice
before (A) or after (B) intraperitoneal treatment for 4 days with 50 n moles of antigenic peptide. Cells were stained with anti-CD8
FITC, anti-CD4 PE, and biotinylated anti-Vl followed by Tricolor-conjugated streptavidin as described in Materials and Methods.
Dot blots represent two-color analysis of cells stained with CD4 and CD8. Numbers represent percent proportion of cells in the
quadrant. (C) Three-parameter data files were software-gated to generate single-color staining histograms of VIlli expression on
CD8/CD4 single-positive cells. Numbers indicate the mean fluorescence ofV staining in arbitrary units. Solid line: V] expres-
sion on total thymocytes from double-transgenic mice. Dashed line: Vu expression on total thymocytes of the control F5 single-
transgenic mouse.TOLERANCE IN NUCLEOPROTEIN/F5TCR DOUBLE-TRANSGENIC MICE 305
1993a). When the Vl profile of total thymocytes
from F5/NP double-transgenic mice was compared
with that of F5 single-transgenic control mice, it be-
came evident that the thymus from F5/H2NP10, F5/
H2NP22, F5/H2NP40, and F5/H2NP47 mice was
almost devoid of the TCRhi population (Fig. 3C).
The findings in the thymus were reflected in the
periphery of F5/H2NP double-transgenic mice.
Lymph nodes of the mice described before were
stained for CD4, CD8, and VI1. Figure 4A shows
that the proportion of CD8 cells was drastically
reduced from an average of 53-68% in F5 single-
transgenic mice to 8-18% of lymph node cells in the
various F5/NP double-transgenic mice. Gated CD8
cells were analyzed for expression of Vl and Fig.
4C shows such analysis. In all F5/NP double-
transgenic mice, the circulating CD8 cells have re-
duced levels of transgenic TCR. However, this re-
duction varied from line to line, with F5/H2NP10
being most and F5/H2NP47 least affected. The
majority of cells with high levels of Vl present in
most double-transgenic mice probably represent
cells expressing endogenous receptors as these are
not as evident in mice that cannot rearrange endog-
enous TCR genes (see Figs 5 and 6).
Because allelic exclusion in TCR mice is not
complete, particularly at the 0-chain gene locus
(Mamalaki et al., 1993b), the presence of double-
positive CD4/8 thymocytes and CD8 VI" periph-
eral cells in F5/NP doubl.e-transgenic mice could be
explained by the fact that they may express endog-
enous 0 and receptors, which allow them to be
positive selected.
To test this possibility, we generated F5/NP dou-
ble-transgenic mice unable to rearrange endogenous
TCR genes. Thus, F5/H2NP mice were bred with
Recombination Activating Gene-l-deficient mice
(RAG-I-/-) (Spanopoulou et al., 1994). Figure 5 shows
that, in the absence of endogenous TCR rearrange-
ment, CD4+8 thymocytes and peripheral CD8 cells
are still present in F5/H2NP22 mice. However, the
CD8 T cells found in lymphoid organs are reduced
in absolute numbers (not shown) and have lower
levels of TCR and its coreceptor (CD8) in compari-
son with CD8 cells from F5/RAG-1-/- (Fig. 5).
The absence of endogenous receptors allowed us
also to compare the levels of TCR on CD8 periph-
eral T cells in different double-transgenic mice. Fig-
ure 6 shows that F5/H2NP22/RAG-1-/- and F5/
H2NP40/RAG-1-/- mice have considerably lower
levels of T-cell receptor than F5/RAG-1-/- single-
transgenic mice or F5/H2NP47/RAG-1-/- double-
transgenic mice. These results indicate that to
maintain tolerance, the levels of TCR adjust to the
amount of antigen present and are consistent with
the F5 T-cell proliferation studies shown in Fig. 2
that reflect variable antigen levels. Thus, mice ex-
pressing high levels of NP (H2NP40 or H2NP22)
downregulate the F5 TCR to lower levels than
mice with reduced expression ofNP (H2NP47). The
levels of TCR in F5/H2NP47 mice appear to be less
affected in RAG-l-/- mice than in RAG-l/// mice. The
reason for this is under investigation at the moment.
It is possible that unresponsiveness in the different
double-transgenic mice is achieved by different
mechanisms.
We conclude from these results that the tolerance
in the double-transgenic mice is mainly due to the
reduction in output of single-positive cells by arrest
and/or deletion at the transition between the
CD4/8+TCRl to CD4/8/TCRhi stage. However, a
small proportion of cells mature to the CD8 single-
positive stage with low levels of TCR and are re-
leased in the periphery even in mice that cannot
rearrange the endogenous TCR genes. No CD4-8-
TCRhi T cells were detected in any of the double-
transgenic mice (not shown).
CD44 Is Upregulated in CD8 from F5/H2NP
Double-Transgenic Mice
CD44 is a marker whose upregulation has been taken
as an indication that T cells have been exposed to
cognate antigen (Budd et al., 1987). F5, F5/H2NP22,
and F5/H2NP47 spleen cells were stained for CD44,
CD8, and Vl1. CD8 Vl cells were gated and
levels of CD44 on their surface were assessed. As
seen in Fig. 7, CD44 is upregulated on CD8 T cells
from double-transgenic mice in comparison with
CD8 T cells from F5 mice. These findings indicate
that these T cells have encountered nucleoprotein.
Similar results were obtained in RAG-1-/’/F5 ex-
cluding the possibility that these T cells express
endogenous receptors that have responded to envi-
ronmental antigens irrelevant to the F5 TCR (data
not shown). These data are in agreement with stud-
ies that described increased levels of CD44 on toler-
ant T cells in transgenic mice expressing the cognate
antigen (von Boehmer et al., 1991; Alferink et al.,
1994).306 C. MAMALAKI et al.
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FIGURE 5. Presence of double-positive thymocytes and mature CD8 cells in F5/H2NP/RAG-l-deficient double-transgenic mice.
Three-color fluorometric analysis was performed on thymocytes or lymph node cells of TCR single-transgenic mice or TCR/NP
double-transgenic mice bred onto RAG-l-deficient mice background. Cells were stained with anti-CD8 FITC, anti-CD4 PE, and
biotinylated anti-Vl antibodies followed by Tricolor-conjugated streptavidin as described in Materials and Methods. Dot blots
represent two-color analysis of cells stained with CD4 and CD8. Numbers represent percent proportion of cells in the quadrant.
Three-parameters data files were software-gated to generate signle-color staining histograms ofVI on total thymocytes (thymus)
or on CD8 cells (lymph node). Numbers indicate the mean fluorescence ofVu staining in arbitrary units. Solid line:V expres-
sion on thymocytes or CD8 lymph node cells from F5/H2NP22/RAG-1-/- double-transgenic mice. Dashed dotted line:V ex-
pression on total thymocytes of the control F5/RAG-1-/- single-transgenic mouse.TOLERANCE IN NUCLEOPROTEIN/F5TCR DOUBLE-TRANSGENIC MICE 307
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FIGURE 6. TCR levels on peripheral CD8 T cells in F5/H2NP/RAG-l-deficient double-transgenic mice. Three-color fluorometric
analysis,was performed on lymph node cells of F5/RAG-1-/-, H2NP22/FR/RAG-1-/-, H2NP40/F5/RAG-1-/-, and H2NP47/F5/
RAG-l-/- mice. Cells were stained with anti-CD8 FITC, anti-CD4 PE, and biotynalyted anti-Vl followed by Tricolor-conjugated
streptavidin as described. Three-parameter data files were software-gated to generate single-color staining histograms of Vl on
CD8 cells.308 C. MAMALAKI et al.
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FIGURE 7. Peripheral CD8 cells from F5/H2NP double-transgenic mice bear upregulated levels of the CD44 memory marker.
Three-color fluorometric analysis was performed on spleen cells from F5 transgenic and F5/H2NP double-transgenic mice. Cells
were stained with anti-CD8 PE, anti-Vl1FITC, and biotinylated anti-CD44 followed by Streptavidin red. Histograms represent the
levels of CD44 on CD8 positive cells in F5, F5/H2NP22, and F5/H2NP47 spleens.TOLERANCE IN NUCLEOPROTEIN/F5TCR DOUBLE-TRANSGENIC MICE 309
Response of Double-Transgenic Mice to
Additional Exposure to Antigen
F5 TCR-transgenic mice respond in vivo to four
daily injections of 50 n moles of the antigenic peptide
by proliferation of the CD8 T cells and by deple-
tion of the double-positive CD4/8 thymocytes
(Mamalaki et al., 1992). To assess to what extent these
phenomena can be seen in similarly treated double-
transgenic mice, we administered 4 daily inter-
peritoneal injections of 50 n moles of NP peptide.
Figure 3B shows representative two-color FACS
analyses of thymocytes stained with CD4 and CD8
following 4 days of peptide administration. F5
single-transgenic control mice treated with peptide
for 4 days show a marked decrease (10-30-fold) of
thymus cellularity. In contrast, F5/H2NP10, F5/
HPNP22, and F5/H2NP40 show a decrease in the
number of thymocytes of approximately 2-3-fold
(data not shown). The exception is double-transgenic
mouse F5/H2NP47, which shows extensive thymic
depletion similar to that seen in the F5 single-
transgenic control mouse after peptide treatment.
In the representative experiment shown in Fig. 3B,
the reduction in the proportion of double-positive
thymocytes in double-transgenic mice treated with
peptide was from 71% to 62% in F5/H2NP10, from
73% to 56% in F5/H2NP22, from 74% to 62% in F5/
H2NP40, and from 86% to 12% in F5/H2NP47 mice.
The proportion ofCD8 T cells in the lymph nodes
of F5/NP double-transg6nic mice did not change
upon exposure to antigenic peptide in vivo (Fig. 4B).
As expected, no change was noted in the expression
of Vl on gated CD8 lymph node cells from F5/
H2NP10, F5/H2NP22, and F5/H2NP40 double-
transgenic mice after, administration of antigenic
peptide (Fig. 8), presumably because most of these
cells express endogenous 0 and/or [ receptors.
However, when F5/H2NP22/RAG-1-/- were treated
with peptide, the transgenic TCR on the few circu-
latingCD8 was further downmodulated (Fig. 8).We
concluded from these results that tolerance in most
F5/NP double-transgenic mice involves the CD8
population and is sufficient to protect the mice from
self-reactivity due to the low levels of TCR and
coreceptor on these cells. However, this tolerance can
be enhanced by exposure to higher levels of antigenic
peptide.
Functional Analysis of T Cells from
Double-Transgenic Mice
To test the functional capability of peripheral T cells
from F5/NP double-transgenic mice or from mice
capable of presenting endogenous superantigen to
the F5 TCR (F5bk) (Mamalaki et al., 1993a), we as-
sessed the proliferative response and the develop-
ment of cytolytic activity by these cells after in vivo
or in vitro stimulation with cognate peptide. Table 1
shows the results of exposing spleen cells from F5bb,
F5bk, and F5/NP double-transgenic mice untreated
or following peptide administration in vivo for 4
days, to H-2b splenic APC, alone or peptide-pulsed,
in the presence of low concentrations of rIL-2
(2.5 IU/ml). In each of the two experiments, spleen
cells from the F5bb control mice made good peptide-
specific proliferative responses before and after
4 days in vivo peptide administration. In contrast,
spleen cells from the F5bk heterozygotes not given
peptide in vivo failed to make a peptide-specific
proliferative response in vitro, although they did so
following exposure to peptide in vivo. None of
the F5/NP double-transgenic mice made peptide-
specific proliferative responses, even after exposure
to peptide in vivo (Table 1). Peptide-specific cytotoxic
T cells were found ex vivo in spleen cells removed
from F5bb and F5bk mice following peptide admin-
istration but never in untreated F5bb or F5bk mice,
nor in any of the F5/NP double-transgenic mice,
whether or not given peptide in vivo (data not
shown). In contrast, spleen cells from all F5bb, F5bk,
and F5/NP double-transgenic mice could develop
peptide-specific cytotoxic effector cells after culture
in vitro for 3 or 4 days in the presence of 20 IU
rIL-2/ml. Table 2 shows the results of cytotoxicity
developed after in vitro culture with rIL-2 and
peptide-pulsed APC.
TABLE
Generation of Peptide-Specific Proliferative Responses In Vitro
from Spleen Cells of F5 Mice Expressing Endogenous
Superantigen or Cognate Peptide from a Transgene
3H proliferation
Experiment Mouse TreatP +B10 +B10P
F5(b) 1,360 10,391
F5(b) 4 dp 1,721 64,417
F5(bk) 2,131 3,058
F5(bk) 4 dp 2,829 10,638
F5/H2NP47 1,094 668
F5/H2NP47 4 dp 1,391 974
F5(b) 422 15,994
F5(b) 4 dp 1,028 112,152
F5/H2NP40 1,676 1,690
F5/H2NP40 1,203 3,099
F5/H2NP40 4 dp 4,557 4,311
F5/H2NP40 4 dp 1,700 3,660
Note: TreatP: In vivo treatment of mice with NP peptide, dp: Days with NP peptide.
B10P: Spleen cells from C57B1/10 mice loaded with NP peptide.310 C. MAMALAKI et al.
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FIGURE 8. Levels of TCR on peripheral CD8 T cells after treatment of double-transgenic mice with antigenic peptide. Three-
parameter data files were software-gated to generate single-color staining histograms of Vu on CD8/CD4 single-positive cells.
Numbers indicate the mean fluorescence of V[I staining in arbitrary units. Solid line:V expression on gated CD8 lymph node
cells from single- or double-transgenic mice before (dashed line) or after (solid line) intraperitoneal treatment for 4 days with
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TABLE 2
Generation of Peptide-Specific Cytotoxicity In Vitro from
Spleen Cells of F5 Mice Expressing Endogenous Superantigen
or Cognate Peptide from a Transgene
Cytotoxicity
Experiment Mouse TreatP EL-4 EL-4P
F5(b) 0 13
F5(b) 4 dp 0 48
F5(bk) 0 23
F5(bk) 0 19
F5(bk) 4 dp 0 55
F5(bk) 4 dp 0 19
2 F5(b) 0 56
F5(b) 4 dp 0 71
F5/H2NP47 9 59
F5/H2NP47 4 dp 10 46
F5/H2NP47 4 dp 8 51
3 F5(b) 3 39
F5(b) 4 dp 52
F5/H2NP40 13
F5/H2NP40 22
F5/H2NP40 4 dp 2 12
F5/H2NP40 4 dp 2 20
Note: TreatP: In vivo treatment of mice with NP peptide, dp: Days with NP peptide.
EL-4P: EL-4 cells loaded with NP peptide.
DISCUSSION
Experiments using normal mice have shown that
mature T cells reactive to endogenous superantigens
are absent in adult mice and that whereas CD4/8
double-positive thymocytes expressing the relevant
TCR V[3 are present, such TCR V[3 cells are absent
or reduced in single-positive T cells in the thymus
and the periphery (Kappler et al., 1987; MacDonald
et al., 1988). Mice transgenic for antigen-specific
T-cell receptors have extended these observations
(Kisielow et al., 1988; Berg et al., 1989; Pircher et al.,
1989; Hhmmerling et al., 1991; Morahan et al., 1991;
Sch6nrich et al., 1991;Auphan et al., 1992; Husbands
et al., 1992; Geiger et al., 1993; Sch6nrich et al., 1993;
Oehen et al., 1994; Sponaas et al., 1994).
In this paper, we studied the forms of negative
selection and tolerance induction caused in F5 TCR-
transgenic mice by nominal antigen when the latter
is expressed in the form of a transgene. In the thy-
mus of F5/NP double-transgenic mice, a complete
absence of F5 TCRhi thymocytes is observed. In
peripheral tissues, CD4 cells appear not to be af-
fected in numbers or in the levels of Vl that they
express. This is consistent with the probability that
CD4 T cells in these mice are selected because they
express endogenous receptors allowing their pos-
itive selection (Corbella et al., 1994). The CD8
peripheral mature population on the other hand is
affected both in numbers and in the levels of Vl
they express. In RAG-l/// mice, the majority of these
CD8 cells probably express endogenous c and/or
[3 chains and this may be the reason they are posi-
tively selected and released in the periphery. It is
possible that these cells, due to the presence of the
antigen, downregulate the transgenic receptor, caus-
ing upregulation of the recombination machinery
and consequently increased rearrangement of the
endogenousTCR gene loci. This would be analogous
to experiments describing receptor editing in self-
reactive B cells (Gay et al., 1993; Tiegs et al., 1993).
In F5/RAG-I-/- mice, we still found CD8 mature
T cells that are tolerant due to F5 TCR and CD8 co-
receptor downregulation. We found a correlation
between the extent of F5 TCR downregulation and
the apparent levels of NP antigen expression on
antigen-presenting cells in H2NP mice. That is, the
more antigen, the lower the receptor. Therefore, it
appears that T cells are capable of adjusting the
expression of their antigen receptor to levels not
capable of responding to the self-antigen. This has
implications in our understanding of autoimmunity
where T cells with potential autoreactive TCRs es-
cape clonal deletion in the thymus and differentiate
to mature T cells with lower levels ofTCR. Such cells,
when encountering foreign antigen of "better fit,"
may be activated and following TCR upregulation
could attack cells expressing self cognate antigen.
An interesting observation concerns the reactiv-
ity of F5 CD8 T cells present in H2bk mice compared
to those found in F5/H2NP double-transgenic mice.
In both cases, CD8 T cells in peripheral lymphoid
organs have low levels of TCR and are present in
lower numbers. However, as we reported before
(Mamalaki et al., 1993a; and this study), F5 CD8 cells
from F5/H2bk mice that are presumably tolerant to
endogenous Mtv antigens still react to cognate anti-
gen (Table 1). On the other hand, F5 CD8 T cells
from F5/H2NP mice only respond to cognate
peptide by downregulating their TCR even further.
This is a similar situation reported with mice
transgenic for a TCR specific for LCMV and an en-
dogenous superantigen (Pircher et al., 1989; Kawai
and Ohashi, 1995).
We conclude from these findings that in F5TCR
mice, negative selection of self-reactive thymocytes,
whether to H-2E/Mtv (MHC Class II restricted re-
activity) or to nucleoprotein (MHC Class I reactiv-
ity), occurs at the transition from CD4+8+TCR to
CD4/8+TCRhi. It is unclear at the moment whether312 C. MAMALAKI et al.
this involves physical elimination of developing
thymocytes at the point of upregulation of the
receptor or arrest of these thymocytes at the TCR1
stage due to the presence of the antigen (Takahama
et al., 1992; Swat et al., 1994).
The picture observed in F5/NP double-transgenic
mice strongly resembles that developing in F5
single-transgenic mice treated with cognate peptide
long term. In such long-term peptide-treated mice,
the thymus contains CD4/8 cells bearing low levels
ofTCR and the peripheral lymphoid organs contain
very few CD8 T cells with low levels of transgenic
TCR (Mamalaki et al., 1993b). Thus, chronic expo-
sure of mice to cognate antigen leads to a situation
similar to tolerance toward self-antigens.
Additional exposure of tolerant T cells to high
levels of antigen in other experimental models has
led to further tolerization of these cells by down-
modulation of the TCR and/or the coreceptor
(Himmerling et al., 1991). Further antigenic expo-
sure of T cells from F5/NP double-transgenic mice
did not enhance their tolerization, judging from the
levels of TCR and coreceptor: These remained un-
changed after treatment with the antigenic peptide.
When we repeated this experiment using RAG-1-/-
mice,we saw that the fewCD8 F5TCR1 cells present
in the periphery did downregulate their receptor and
coreceptor even further upon exposure to higher
levels of antigen given as exogenously administered
peptide. This is in agreement with evidence from an
alloreactive transgenic TCR model (Himmerling
et al., 1991), and confirms that whereas the tolerance
induced in double-transgenic mice is sufficient for
the levels of nucleoprotein transgene expressed,
however, when higher levels of antigen are intro-
duced, the cells downregulate their TCR even fur-
ther.
Despite unresponsiveness in vivo, stimulation of
T cells from double-transgenic mice was possible
in vitro. Peripheral splenic T cells from all F5 mice,
whether expressing a "deleting" endogenous super-
antigen or a cognate peptide-generating transgene,
can generate peptide-specific cytotoxicity after
in vitro culture 72-96 hr in the presence of moderate
doses (20 IU/ml) of rIL-2. This shows that the ap-
parently anergic phenotype manifest in vivo can be
converted to activation in the presence of IL-2. This
is one of the hallmarks of anergic T cells and per-
haps should not surprise us. On the other hand, the
observation that the proliferative capacity of these
anergic T cells is severely compromised is an inter-
esting one, suggesting that whereas terminal differ-
entiation into effector cells is still possible, clonal
expansion is not. The F5/NP double-transgenic mice
cannot be distinguished from each other in this re-
spect, but the F5bk mice are different in that their
spleen cells followingn vivo exposure to exogenous
cognate peptide will subsequently clonally expand
on in vitro stimulation with peptide-pulsedAPC. The
extent to which F5 T cells are restrained in vivo in
the continuous presence of potentially activating
antigen is a measure of the capacity of the organism
to control autoreactivity. The fail-safe mechanisms
could clearly involve downregulation of TCR and/
or accessory molecules, as documented in this pa-
per, but the ubiquitous presence of antigen on non-
professional APC cells in the periphery also could
have an inhibitory effect on the activation cascade
via molecular interactions at present poorly under-
stood.
In a study by Oehen et al. (1994), it was shown
that in double-transgenic mice for LCMV glyco-
protein and a TCR specific for this antigen, when
the antigen is expressed at low levels, transgenic
TCR T cells are partially deleted. However, these
T cells retain their capacity to proliferate and mount
a cytolytic response. In our system of double-
transgenic mice with even the lowest levels of anti-
gen expression, TCR T cells do not respond in vivo,
do not proliferate when stimulated by antigen
in vitro, and develop cytolytic activity only after cul-
ture in vitro with IL-2. These differences may reflect
variations in TCR/MHC-Ag affinities.
Results in this and previously published papers
indicate that negative selection in the thymus can
take place at different stages of thymocyte develop-
ment with the ultimate result the absence of mature
TCRhi self-reactive T cells. This can be accomplished
as early as during the transition from CD4-8-TCR-
to CD4/8+TCR (H-Y-, LCMV, MHC-specific TCRs)
or later during the transition from CD4/8/TCR to
CD4+8/TCRhi (H-2E/Mtv+-specific TCRs, F5/H2NP).
The actual stage in development in which dele-
tion of self-reactive clones or the establishment of
their unresponsiveness occurs is most likely depend-
ent on the affinity of the TCR for the MHC/peptide
ligand, on the site of expression of the deleting ligand
(cortex/medulla), the type of cells that express
the deleting ligand, and finally the levels of this
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MATERIALS AND METHODS
Mice and Gene Constructs
was performed with a FACScan laser instrument and
Lysis I or II program (Becton Dickinson).
Mice were generated and maintained in a conven-
tional colony free of pathogens at the National Insti-
tute for Medical Research in London, F5 TCR and
H2NP transgenic mice were generated as described
previously (Lang et al., 1988; Mamalaki et al., 1993a)
using inbred C57B1/10 mice. Influenza nucleo-
protein peptide (0366-374) was dissolved in PBS
and injected intraperitoneally as indicated in the
figure legends.
The H2NP fragment for microinjection was con-
structed by combining fragments containing the H2-
Kb promoter, the influenza nucleoprotein coding
sequences, and the SV40 splice and polyadenylation
signal in three steps: First, a BamHI-SmaI fragment
from the pBG311 expression vector (Cate et al., 1986)
was cloned in the BamHI-SmaI sites of the polylinker
of Bluescript (Stratagene). This fragment contains the
SV40 small-t-antigen gene-splice sequence, the large-
T-antigen gene-polyadenylation sequence, and part
of a polylinker including SmaI-, NdeI, SstI, and BglII-
restriction sites. Second, in the BglII site of this
polylinker was inserted a BamHI fragment from
the PUC9/IMP1295 plasmid (Davey et al., 1985;
Townsend et al., 1985) that contains sequences cod-
ing for 0c1, 2, and 328-498 of the nucleoprotein from
the influenza virus (the deletion removes amino
acids 3-327). Third, the resulting plasmid was
cleaved at the EcoRI site of the Bluescript polylinker
and the SmaI site described in the first cloning step
and an EcoRI-NruI fragment from the H2-Kb pro-
moter was inserted (Weiss et al., 1983). The micro-
injection fragment was isolated free from vector
sequences by digesting with EcoRI and NotI.
Flow Cytometry
For three-color analysis, 10 thymocytes or lymph
node cells were stained with the following anti-
bodies in different combinations: phycoerythrin-
conjugated anti-CD4 (GK1.5) (Becton Dickinson),
fluorescein isothiocyanate-conjugated anti-CD8 (53-
6.7) (Becton Dickinson), phycoerythrin-conjugated
anti-CD8 (YTS 169.4) (Coulter Immunology), bi-
otinylated anti-Vl (KT11) (Tomonari and Lovering,
1988) and biotinylated anti-CD44 (pgp-1) (kind gift
from Dr Stockinger), followed by a second layer of
Tricolor-conjugated streptavidin (Caltag) or strep-
tavidin red 670 (Gibco). Three-color FACS analysis
Isolation of Antigen in Presenting Cells
Antigen-presenting cells were prepared by a modi-
fied protocol published previously (Tanaka, 1993).
Thymuses and spleens from adult B10, NP40, and
NP47 mice were teased gently and placed in a cock-
tail with collagenase (Worthington, Biochemical
Corp., Freehold, NJ; 1.6 mg/ml) and DNAse (Sigma,
0.1%) in RPMI for 1 hr at 37C. The cells were
washed, resuspended, and plated in RPM110% FCS.
Contaminating red cells were removed by hypotonic
shock. After 2 hr incubation, the nonadherent cells
were washed off and adherent ones were cultured
overnight at 37C. After 18 hr, the dendritic cells were
recovered as the nonadherent population. To mini-
mize the contamination with thymocytes and T cells,
the pooled cells were washed with PBS and treated
with 5 mM EDTA for 10 min at room temperature.
The adherent cells were identified as macrophages
by their distinctive morphology and were treated
with trypsin/EDTA for 30 min, washed twice,
resuspended, and plated in RPMI 10% FCS. Cells
were sensitized with NP366-374 by adding 20 gM/
ml of peptide for I hr at 37C, then washed twice in
medium, and resuspended.
Cytotoxic T-cell Assays
These were carried out using as targets EL-4 cells
growing in log phase in vitro: Two aliquots of 2 x 106
EL-4 were labeled for 60 min at 37C in 0.1 ml BSS
medium containing 100 gCi 51Cr sodium chromate;
to one aliquote, 100 gl of 100 gM influenza nucleo-
protein peptide (NP366-374) was also added at the
beginning of the 60-min incubation. After incuba-
tion, both aliquots of EL-4 were washed twice and
then resuspended in complete RPMI medium at I x
105/ml before dispensing 100 gl (1 x 104) into each
microtitre well into which serial dilutions of effec-
tor T cells had been placed.
Effector cells generated in MLC from spleen cells
of transgenic mice, cultured at 2 x 106 cells per 2-ml
well at 37C in a 5% CO atmosphere for 3 to 5 days
in the presence of 25 IU/ml human rIL-2 with or
without 5 x 106 irradiated cells per well of C57BL/10
spleen cells sensitized or not with NP366-374
peptide, as described before. Effector cells were
harvested, centrifuged, and resuspended in fresh314 C. MAMALAKI et al.
complete RPMI medium, counted, and then volumes
adjusted to give concentration of 3 x 106/ml. Each
effector cell suspension was dispensed in round-
bottomed microtitre wells in a volume of 100 tl in
triplicate and then four serial, one in three dilutions
were carried out. After addition of 1 x 104 target
cells/well, effector-to-target-cell ratios of 30:1, 10:1,
3:1, and 1:1 were present. The assay plates were
briefly centrifuged then incubated for 3 hr at 37C
in a 5% CO atmosphere. One hundred microliters
of supernatant was then harvested from each plate
and counted for gamma rays. The percent specific
lysis was calculated according to the formula
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